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Many Candida species are commensals
of the oral mucosa. They are usually
innocuous, but when conditions are favor-
able, they can proliferate and cause disease.
Candida spp. are readily isolated from vari-
ous sites within the oral cavity, but simple
carriage does not inevitably result in the
development of clinical symptoms. Whether
the organism remains as a commensal, or
proliferates and causes disease, is usually
determined by preexisting or concomitant
alterations in the integrity of the immune
system.
Oral candidiasis is seen most frequently
in patients at-risk, such as those suffering
from HlV/acquired immunodeficiency syn-
drome (AIDS), immunosuppression, dia-
betes, xerostomia, or those wearing dentures
(Fotos and Hellstein, 1992); however, clini-
cal observations in these and other patient
groups have suggested that these predispos-
ing factors are almost invariably associated
with deficiencies in innate and adaptive
immune functions that compromise effective
host responses against the infection. The
seminal observations by Kirkpatrick and
colleagues (1971) on children with chronic
mucocutaneous candidiasis (CMC) strongly
implicated defects in cell-mediated immu-
nity as a major predisposing factor, and the
importance of T lymphocytes, and CD4+
cells in particular, has been confrrmed by the
high incidence of oral candidiasis in HIV-
infected individuals whose CD4* lympho-
cyte counts are declining.
In this chapter, the epidemiology of the
disease, associated risk factors, and clinical
features are briefly outlined. This is fol-
lowed by,reviews of the host immune factors
relevant to recovery from oral infection in
humans and mice, and the discussion con-
cludes with an evaluation of the ways in
which these immune mechanisms may
relate to the clinical manifestations of the
disease.
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2. Epidemiology of Oral
Gandidiasis
2.1. Candida Species
Candididsis is most commonly caused by
the yeast C. albicans, and to a far lesser
extent by C. glabrata, C. krusei, C. tropicalis,
C. pseudotropicalis, C. parapsilosis, and C.
guilliermondi (Odds, 1988). More recently,
oral candidiasis in HlV-positive individuals
has been associated with C. dubliniensis
(Sullivan et al., 1995).
C. albicans is a commensal residing in the
oral cavity of the majority of healthy per-
sons (Odds, 1988). It is a dimorphic fungus
that can exist both in a yeast phase (blas-
tospore, blastoconidial) and a hyphal
(mycelial) phase. Depending on the environ-
mental conditions, they may develop either
in the mycelial form, composed of long
branching septae or filaments, or as spheri-
cal or ovoid yeast cells. In the yeast phase
C. albicans are from 2-8 to 3-14 pm in size,
but hyphae can extend a few hundred
micrometers (Saltarelli, 1989). They repro-
duce by multilateral budding and do not
undergo a sexual cycle. Dimorphism is rele-
vant both to the pathogenicity of the yeast
and to the clinical problems of diagnosis
and treatment (Saltarelli, 1989).
C. albicans is the most common Candida
species isolated from the oral cavity both in
the healthy and the diseased (Samaranayake
and MacFarlane, 1990). Symptom-free oral
carriage of Candida organisms has been rec-
ognized for many years, with the reported
prevalence ranging from 3o/o to 48Yo in clini-
cally normal mouths of healthy adults
(Arendorf and Walker, 1980), and 45oh to
65% in healthy children (Odds, 1988). The
oral carriage of yeasts is higher in hospital-
ized than ambulant patients, with a median
carriage rate of 54.70/, for all species and
38.1% for C. albicans alone (Wilkieson et a1.,
1991).
Oral Gandidiasis: Glinical Manifestations and Gellular Adaptive Host Responses 61
In the past C. dubliniensis was probably
identified as an atypical strain of C. albi-
cans. Although it was initially found to col-
onize the oral cavity and to be a cause of
oropharyngeal candidiasis (OPC) in HIV-
positive patients (Sullivan et a1., 1995), it has
since been found to colonize and infect var-
ious other groups (Redding, 2001;
Kantarcioglu and Yucel, 2002; Tekeli et al.,
2002). Incidence rates for C. dubliniensis irr
oral cultures from adults vary from 37o in
asymptomatic HlV-negative individuals to
32% in HlV-positive patients with clinical
signs and symptoms of OPC (Coleman
et al., 1997; Meiller et al., 1999; Fisher et a1.,
2001; Giammanco et al., 2002). C. dublinien-
sls has also been detected in pediatric
patients (Sano et al., 2000), with one study
reporting positive cultures in ll"/o of HIV-
positive pediatric patients (Brown et al.,
2000). Mixed infections, especially with C.
albicans, are common in patients who are
positive for oral C. dubliniensis (Schorling
et al., 2000).
C. glabrata is much less pathogenic than
C. albicans, but in recent years it has
emerged as a significant pathogen in
humans. It is currently the second to third
leading cause of candidiasis of all kinds and
comprises approximately 5Yo of all Candida
isolates (Thuraisingam and Denning, 2000).
The role of C. glabrata in OPC is controver-
sial, and the yeast is mostly seen in cases of
systemic candidiasis. C. glabrata is com-
monly isolated along with C. albicans when
cultured from patients with OPC. C.
glabrata makes up between 5Y:o and l0%o of
all oral isolates recovered from HlV-positive
patients who have OPC (Fidel et al.; 1999).
OPC can be caused solely by C. glabrata
(Hoegl et al., 1998), with one study report-
ing that up to l4o/o of all oropharyngeal
infections were caused by this species
(Masia Canuto et al., 2000). It was esti-
mated that approximately 30o/o of patients
over 80 years of age were colonized orally
with C. glabrata (Lockhart et al., 1p99), but
the percentage was almost doubled if the
patients wore dentures.
OPC caused by C. tropicafts has been
reported but is relatively rare. Colonization
on the other hand is quite common; approx-
imately 6Yo of yeast isolates other than
C. albicans in HlV-positive patients are C.
tropicalis (Cartledge et al., 1999). It is a
pathogenic organism, especially in patients
receiving chemotherapy for hematologic
malignancies, and OPC associated with
C. tropicalis can cause fungemia in these
patients (Redding, 2001).
Oral colonization with C. krusei is com-
mon, making up approximately 20o/o of
yeasts other than C. albicans cultured in
HlV-positive patients (Cartledge et al.,
1999), but OPC caused by C. krusei alone is
rare.
2.2. Palhogen Risk Factors
Oral infection with Candida is associated
with certain pathogenic variables. Adhesion
of the yeast to epithelial cell walls, an impor-
tant hrst step of infection, is promoted by
fungal wall components such as mannose,
C3d receptors, mannoprotein, and saccha-
rins (Ghannoum et al., 1986; Brassart et al.,
1991; Kanbe et al., 1991). Hydrophqbicity
(Hazen et al., 1991) and the ability to bind
tb host fibronectin (Klotz and Smith, 1991)
are also important pathogenic mechanisms
used by the yeast in the initial stages of
infection. Some other factors important in
host infection include germ tube formation
(Sobel et al., 1984), presence of mycelia
(Saltarelli et al., 1975), endotoxins (Culler
et al.,1972), and proteinases (Kwon-Chung
et al., 1985).
The family of secreted aspartyl pro-
teinases (SAPs) are considered to be one of
the more important of the putative virulence
factors of C. albicans. Analysis of patients
with asymptomatic Candida carriage, and
those with oral candidiasis, showed that
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SAP2 and SAPs 4 to 6 were expressed in
both subpopulations, whereas SAPI and
SAP3 were observed only in patients with
oral disease (Naglik et al., 1999). More
extensive studies (Naglik et al., 2003a) con-
firmed that SAP2 and SAP5 were the most
common genes expressed uring both infec-
tion and carriage, whereas expression of
SAPI, SAP3, SAP4, SAP7, and SAP8 corre-
lated with oral disease. Using an in vitro
model, the gene products of SAPsI to 3, but
not SAPs4 to 6, appeared to be predomi-
nantly responsible for damage to reconsti-
tuted human epithelium (Schaller et a1.,
1999), although studies with specihc SAP
mutants suggested that the yeast may have
the ability to compensate for the loss of one
SAP gene by the upregulation of others.
Interestingly, viable' but not heat-killed
Candida, was able to induce increased
expression of genes coding for a variety of
immunologically rblevant cytokines and
chemokines by epithelial cells (Schaller
et a1.,2002), and cytokine production corre-
lated with the virulence of the organism.
This suggests that the "quality" of the infec-
tious challenge may influence the nature of
the immune response elicited. This concept
will be considered later, in relation to the dif-
ferent manifestations of oral infection.
2.3. Host Risk Factors
Although the transition from commen-
salism to disease may be associated with the
virulence characteristics of the organism, it
is widely accepted that host factors are of
paramount importance in the development
of the infectiot Candida spqcies are strictly
opportunistic pathogens, which cause dis-
ease when the host defenses are defective-
hence the designation "disease of the
diseased" given to Candida infections
, (Trousseau, 1869).
The local intraoral environmental milieu,
such as the presence of prostheses, plays a
crucial role in the disease process. Indeed it
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is the combination of the microbial viru-
lence factors, environmental factors, and
host defense factors that determines the ulti-
mate outcome of infection. The major local
and systemic factors that predispose
humans to candidiasis have been classif,red
as natural, dietary, mechanical, and iatro-
genic (Odds, 1988), but only those relevant
to immune dysfunction are considered here.
Host defense mechanisms are impaired
in patients with malignant disease, particu-
larly as a consequence of chemotherapy and
radiotherapy. Longitudinal studies of
patients undergoing radiation therapy to the
head and neck show signihcant increases in
Candida species counts on the tongue sur-
face, in whole saliva, and in dental plaque
(Epstein et al., 1984; Samaranayake t al.,
1988). Therapeutic interventions can also
reduce numbers and impair the function of
polymorphonuclear and mononuclear
phagocytes, leading to oral candidiasis
(Kostiala, 1986).
Chronic hyperplastic candidiasis may
occur as part of CMC, often with identifi-
able immunologic or endocrine abnormali-
ties as major factors. Endocrine disorders
such as hypothyroidism, hypoparathy-
roidism, and adrenal insufliciency, have a
familial incidence and are found in children
and young adults, particularly in girls. The
most frequently associated endocrine mani-
festations include idiopathic hyperparathy-
roidism and hypoadrenocorticism' but
candidiasis follows only where there is an
immune defect (Kostiala et al',1979)-
Fungal infections, particularly atrophic
and pseudomembranous candidiasis, are
common in patients with HIV infection. The
immunodehciency affecting T helper lympho-
cytes during HIV infection makes patients
with the disease more predisposed to second-
ary infections, notably opportunistic Candida
infections. The first patient diagnosed with
AIDS presented with oral candidiasis
(Gottlieb dt a1., 1981a), and oral candidiasis
was a common feature in patients who even-
tually developed AIDS (Gottlieb et a1.,
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1981b). Oral candidiasis occurs in 75oh of
HlV-positive patients @almer et al., 1996) and
9T/o of patients diagnosed with AIDS had
oral candidiasis (McCarthy et al., 1991).
Indeed more than 90oh of patients who are
HlV-positive will develop at least one episode
of oral candidiasis during the progression to
AIDS. The erythematous variant is most fre-
quently seen in these patients, followed by the
pseudomembranoug angular cheilitis, and
then hyperplastic candidiasis (Samaranayake
and MacFarlane, 1990).
A myriad of immunological abnormali-
ties occur as a consequence of HIV infec-
tion, particularly as the disease progresses to
AIDS (Fauci, 1993). Monocytes and
macrophages express CD4, and HIV can
directly infect these cells (Alkhatib et al.,
1996). There are also other alterations to
mononuclear phagocyte function including
alterations in phenotypic marker expression,
?rccessory cell function, chemotaxis,
cytokine production, and respiratory burst
activity (Ho et a1., 1994; -Irial et al., 7995;
Wahl et al., 1996). Nonetheless, profound
CD4+ T cell depletion is the immunological
hallmark of AIDS, and is the most likely
factor accounting for the increased suscepti-
bility of these patients to opportunistic
infections. The role for CD4+ T cells in host
resistance against opportunistic fungal
infections is supported by the frequent
occurrence of fungal infections'in patients
with idiopathic CD4+ T cell lymphocytope-
nia, a condition characterized by low CD4+
counts in the absence of HIV infection
(Duncan et al., 1993).
Oral candidiasis occurs in association
with congenital defrciencies'in both innate
and adaptive immunity. Chronic recalcitrant
mucocutaneous candidiasis is particularly
common in patients with DiGeorge's syn-
drome (Cleveland et al., 1968), a condition
characterized by depletion of T cells in the
thymus-dependent areas of lymph nodes and
in peripheral blood due to thyrnic hypopla-
sia. Patients with severe combined immun-
odeficiency (SCID) syndrome demonstrate
multiple defects in cell-mediated immune
functions, and frequently suffer from CMC
that may disseminate to other tissues (Porter
and Scully, 1990). Syndromes that affect
innate immunity include hereditary
myeloperoxidase (MPO) deficiency, in which
the lack of MPO in the granules of poly-
morphonuclear leukocytes (PMNLs) and
macrophages results in impaired killing of C.
albicans (Lehrer and Cling 1969; Klebanofll
1970), and predisposes to recurrent episodes
of oral thrush or CMC in these patients
(Lehrer and Cline, 1969; Kirkpatrick et al.,
l97l). Patients with Chediak-Higashi syn-
dromg an autosomal recessive disease pre-
senting with abnormal neutrophils,
neutropenia, and impaired chemotaxis
(Wolff, 1972; Oliver and Essner, 1975), also
commonly suffer from candidal infections.
3. Glinical Manifestations
of Oral Candidiasis
The classificationof oral candidiasis has
been fraught with difficulties and complica-
tions, due to the many manifestations the
disease can take and because of the multi-
faceted etiology of the different conditions
involved. Recently, it has been suggested
that oral candidiasis can be arranged into
two categories based on the distribution of
the lesions (Scully et al., 1994): Category.I,
candidal infections conhned to oral and
perioral tissues (primary oral candidiasis)
and Category II, disorders where oral can-
didiasis is a manifestation of generalized
systemic mucocutaneous candidal infection
(secondary oral candidiasis). Category II
lesions are divided into subgroups, which
take into account CMC and other immune
defect disorders such as SCID syndromg
DiGeorge's syndromg and AIDS.
The following clinical ilescriptions are
based on revised classifications by Sama-
ranayake and Yaacob (1990), Holmstrup





Pseudomembranous candidiasis is char-
acterized by whitish-yellowish creamy
patches on the surface of the oral mucosa
and tongue (Fig. 4.la). The lesions develop
into confluent plaques that resemble milk
curds and can be wiped off to reveal a raw
eqythematous base (Odds, 1988). The plaques
consist of necroticmaterial and desquamated
parakeratotic epithelium, penetrated by
C. albicans yeast cells and hyphae that invade
as far as the stratum spinosum. Edema and
microabscesses containing PMNLs are found
in the outer layers of the epithelium. The
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deeper parts of the epithelium show acant
sis, and the inflammatory response in
connective tissue comprises lymphocy
plasma cells, and'PMNL (Odds, 1988). I
form of the disease is most commc
found in infants, the elderly, and those ter
nally ill (Finlay, 1986), particularly in con
nation with severe underlying conditi
such as leukemia, and HIV and AI
(Samaranayake and MacFarlane, I 990).
3.2. Erythematous Gandidiasi
This condition is mainly associated v
the use of corticosteroids or broad-spectr
Figure 4.1. Clinical presentation of acute pseudomembranous candidiasis (A), chronic mucoc
neous candidiasis (B), Candida-associated denture stomatitis (C), angular cheilitis (D),
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Figure 4.1. Cont'd median rhomboid glossitis (E), and hyperplastic andidiasis (F). (Reprinted lrom
publication Clinics in Dermatology, 18: 553-562, Farah, et al. "Oral Candidosis" O 2000 with permis-
sion from Elsevier Inc.)
antibiotics. More recently it has commonly
been seen in HlV-positive patients (Dodd
et a1., 1991). Clinically, it is characterized by
erythematous areas generally on the dorsum
of the tongue, palatg or buccal mucosa.
Lesions seen on the dorsum of the tongue
classically present as depapillated areas
(Scully et al.,1994). The condition is relatively
rare, but in the acute form it is consistently
painful (Lehneq 1967). The histopathology
of acute erythematous candidlasis is essen-
tially like other forms of the disease, with
pseudohyphae penetrating and extending
into the superficial epithelium. The inflam-
matory reaction is characterized by neu-
trophils in the epithelium and a lymphocytic
infiltrate in the connective tissue.
3.3. Chronic Hyperplastic
Gandidiasis
Hyperplastic candidal lesions are
chronic, discrete raised lesions that vary
from small, palpable, translucent, whitish
areas to large, dense, opaque plaques
(Fig. a.1f). The homogeneous form presents
as a uniform adherent white plaque, whereas
the nodular (speckled) lesion has a clinical
appearance of multiple white nodules on an
erythematous background (Walker and
Arendorf, 1990). Neither Iesion will rub off.
Hyperplastic candidiasis usually occurs on
the inside surface of the cheeks, palate, and
tongue (Walker and Arendorf, 1990).
Biopsy is important, as the condition is pre-
malignant and shows varying degrees of
dysplasia (Samaranayake and MacFarlane,
1990). Histopathological examination of the
lesions reveals parakeratosis howing irregu-
lar separation and epithelial hyperplasia,
with Candida invasion restricted to the
upper layers of epithelium (Daniels et al.,
1985). Polymorphonuclear microabscesses
form in the epithelium beneath the candidal
hyphae, with a poorly demarcated chronic
inflammatory infiltrate of lymphocytes and
plasma cells in the upper half of the corium.
Mitotic activity is often increased, but
restricted to the basal and suprabasal layers
of the stratum spinosum. Epithelial dyspla-
sia is more common in the nodular form
(Walker and Arendorf, 1990).
3.4. Candida-associated
Denture Stomatitis
Classically this condition presents
as chronic erythema and edema of the
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denture-bearing mucosa. especially under
maxillary prostheses (Fig' a'1c)' The patient
is usually symptom-free, but may complain
of slighi soreness and angular cheilitis can
be a presenting complaint' Other factors
such as bacterial accumulation, reduced
salivary protection, and mechanical irrita-
tion may be implicated in denture stomatrtls'
which is present in approximately 50% of
complete denture wearers (Budtz-Jorgensen'
tlZ+;. Uistotogical examination of the tis-
sues beneath the dentures shows prolifera-
tive or degenerative responses (Razek and
Shaaban, ilZa; *lttt reduced keratinization
and thinner epithelium (Watson and
MacDonald, 1982). Tissue invasion by
Candida does not occur as commonly as
other forms of oral candidiasis, and rela-
tively little yeast is isolated from the mucosal
surface (Budtz-Jorgensen, 1 974)'
3.5. Angular Gheilitis
Clinically, angular cheilitis presents as
sore, erythematous, fissured lesions, affect-
ing the angles of the mouth, and is com-
monly associated with denture stomatltls
(Fig. a.ld) (Budtz-Jorgensen, 1974)' In
orofacial granulomatosis, a signif,tcant num-
ber of patients have angular cheilitis
(Samaranayake, 1988), and it may also be
,."n in AIDS (SamaranaYake and
Holmstrup, 1989). As mentioned earlieq the
condition can be associated with iron defu
ciency anemia or vitamin B,, deficiency
(Scullv and Cawson, 1998)'
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Occasionally, midline glossitis presents with
a hyperplastic exophytic or lobulated
upp.-un".. Histopathologically, candidal
tr-yptrae are seen invading the superficial lay-
"ir of tn" parakeratotic epithelium with
elongated hyperplastic rete ridges extendlng
into the corium, a PMNL inhltrate occupy-
ing the epithelium, and a lymphocyte infil-
tration in the corium erupting into the bases




Median rhomboid glossitis is character-
ized by an area of papillary atrophy that-is
elliptical or rhomboidJike, symmetrically
placed and centered at the midline of the
tongu", anterior to the circumvallate papil-
tue if ig. 4.1e) (Walker and Arendorf, 1990)'
3.7. Ghronic Mucocutaneous
Candidiasis
CMC is a term given to a grouP of het-




oi the mouth, skin, and nail beds, some-
times producing granulomatous masses over
the face and scalp (Fig' a'1b) (Kirkpatrick
et al.,1977; Edwards et al', 1978)' The prin-
cipal clinical features include chronic oral
candidiasis, chronic cutaneous candidiasis'
and chronic vulvovaginal candidiasis
(Chilgren et al.' 1967)' Oral candidiasis has
beer, 
-obre.u"d 
in more than 90% of all
CMC patients (Odds, 1988)' The tongue, can
b""or.re enlarged, fissured, and may have
hyperplastic nodules on the lateral borders'
pui"i"f angular cheilitis is frequent (Porter
and Scully, 1990). CMC is associated with a
variety of primary immunodeficiencies
such as SCID syndrome, Nezelof's syn-
drome (thymic alymphoplasia), DiGeorge
syndrome- (congenital thymic aplasia)'
hype.irnmrrnoglobulin E syndrome' MPO
dlhciency, and endocrine disorders' espe-
cially Aidison's disease and hypoparathy-
roidism (Porter and Scully, 1990, 1993a'b)'
The oral lesions of CMC have histopatho-
logical features similar to those of chronic
"alnAidiasls (Cawson and Lehner, 1968)'
although candidal infection can occasion-
ally spread into the pharynx, larynx' or
.sophag,.s, but further visceral involvement
is rare (Porter and ScullY, 1990)'
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4. Cellular Adaptive Host
Responses
4.1. Clinical Studies
CMC is frequently seen in association
with endocrinopathies (Kirkpatrick et al.,
1971), but it is generally recognized that the
main predisposing factor is a defect in cell-
mediated immunity (Kirkpatrick, 1994).
These patients can be grouped according to
their specific abnormalities in immunological
responsiveness (Kirkpatrick, I 989), but there
is to Candida-specific defect common to all
groups. Nevertheless, therapy directed at
restoration of cellular immune function gen-
erally results in remission, and the demon-
strable link between systemic cell-mediated
immunity and mucosal defense mechanisms
has been crucial in developing an under-
standing of the pathogenesis of the disease.
The link between CMC, immunodefi-
ciency, and endocrinopathies is now well-
recognized, but with the spread of HIV
infection and AIDS, and the increasing use
of aggressive chemotherapeutic regimens for
transplantation and cancer patients, severe
oropharyngeal infections are appearing in a
much greater variety of clinical contexts.
These include situations in which there is
a deficiency in cell-mediated immune
responses, as well as others in which the
dominant feature is neutropenia. These
observations uggest that host responses
against oral and OPC may involve not only
cells of the adaptive immune response, but
also phagocytic cells, and other nonspecific
innate immune effector mechanisms.
Human epithelial cells from the oral cav-
ity have recently been shown to possess
inhibitory activity against both Candida
yeasts and hyphae (Steele et al., 2000). The
anti-Candida activity required cell contact,
and in these experiments, neither' saliva
nor culture supernatants alone inhibited
Candida growth, nor was the epithelial cell
activity enhanced in the presence of saliva.
Although differential staining showed that
the effect of the epithelial cells was can-
didastatic rather than candidacidal
(Nomanbhoy et a1.,2002), the phenomenon
may be of some biological significance, as
epithelial cell anti-Candida activity was sig-
nificantly lower in HlV-positive patients
with OPC (Steele et al., 2000). The oral
epithelial cells may also act to enhance effec-
tor cell activity through the production of
cytokines and/or chemokines that increase
recruitment of phagocytic cells and stimu-
late innate immunity.
After challenge with C. albicans, primary
oral mucosal epithelial cells and oral epithe-
Iial cell lines produced interleukin-8 (IL-8)
(Dongari-Bagtzoglou and Kashleva, 2003b),
and a proportion also produced granulo-
cyte-macrophage colony-stimulating factor
(GM-CSF) (Dongari-Bagtzoglou and
Kashleva, 2003a). Both responses were
dependent on physical contact with viable
yeasts and were optimal when the yeast ger-
minated into hyphae. IL-8 secretion was
dependent, at least in part, on autocrine
production of IL-lo (Dongari-Bagtzoglou
and Kashleva, 2003b). In addition, oral
fibroblasts have been shown to produce
both IL-6 and IL-8 after exposure to C. albi-
cans in culture (Dongari-Bagtzoglou et al.,
1999). Thus, the oral mucosa may, after
infection, produce a cytokine microenviron-
ment that is able to influence the develop-
ment and maturation of the cell-mediated
immune response against the yeast.
It is currently believed that host
responses against C. albicans are determined
predominantly by the relative dominance of
Thl-type cytokines that lead to recovery
and the development of protection, or Th2-
type cytokines, that are associated with sus-
ceptibility to infection (Romani, 1999).
However, studies in humans have given vari-
able results. Adult patients with chronic oral
candidiasis showed significantly lower
levels of serum IFN-y healthy controls
(Szkaradkiewicz et al., 1998), but there have
been no more recent studies of oral candidi-
asis in the absence of other infections.
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Analysis of salivary cytokine profiles in
normal (HlV-negative) individuals showed a
Th0/Th1 profile, whereas in HlV-positive
individuals, it was of a predominantly Th2-
type (Leigh et a1., 1998), apparently as a
consequence of a reduction in Thl-type
rather than an enhancement of Th2-type
cytokines. HlV-positive individuals with
OPC tended to show a more exaggerated
Th2-type salivary cytokine profilg but the
relevance of this to the pathogenesis of the
Candida infection is unclear at present. Both
HlV-positive and HlV-negative patients dis-
played Candida-specific lymphocyte prolif-
erative responses, and although skin test
reactivity to C. albicans antigens in HIV-
positive patients with low CD4+ cell counts
was reduced compared to controls (Leigh
et a1., 2001), there were no consistent differ-
ences in systemic immune responses that
correlated with the development of OPC.
Denture stomatitis is another manifesta-
tion of oral infection with C. albicans,
although the extent of colonization appears
to be related to the severity of the inflam-
mation induced by external factors, such
as smoking or the wearing of dentures at
night (Barbeau et al., 2003). Patients with
Candida-associated denture stomatitis show
impaired responses against antigens of
C. albicans, as demonstrated by skin test
and leukocyte migration inhibition assays
(Davenport and Wilton, 1971), and may
have overactive suppressor T cells or other
lymphocyte/phagocyte defects (Iacopino
and Wathen, 1992), indicating that normal
immunoregulatory responses can also be
impaired.
Nevertheless, analysis of salivary
cytokines in HlV-negative individuals either
with or without denture stomatitis demon-
strated a mixed ThllTh2 profile (Leigh
eI a1.,2002), with no significant differences
between the two groups, indicating that sus-
ceptibility to Candida-associated enture
stomatitis in the immunocompetent patient
was not associated with a bias towards pro-
duction of Th2-type cytokines. In contrast,
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analysis of semm levels of interleukins and
their soluble receptors found significant
increases in the concentrations of IL-6 and
TNF-o in both patients with dentures, and
those with denture stomatitis, compared to
normal controls (Pietruski et al., 2000),
whereas concentrations of soluble TNF
receptor were reduced in these same groups.
Phenotypic analysis by immunohisto-
chemistry and electron microscopy of cells
of the oral mucosal immune system present
in biopsies of erythematous and
pseudomembranous candidiasis in HIV-
positive patients has shown that the superfi-
cial lamina propria and basal epithelial layer
was populated by CDla* Langerhans cells,
with an inliltration of CD8* lymphocytes.
CD36* dendritic macrophages and lympho-
cytes were detected within the submucosa,
although CD4t cells were absent from the
inlltrate (Romagnoli et al., 1997). In the
pseudomembranous form, CDl4* leuko-
cytes were found in the basal epithelial
layer. Langerhans cells were signihcantly
more numerous in erythematous than in
pseudomembranous candidiasis. It is clear
that oral candidiasis is associated with per-
turbations in the number and state of differ-
entiation of lymphocytes and dendritic cells,
these being more severe in the pseudomem-
branous than in the erythematous form.
These alterations may play a role in the
pathogenesis and evolution of the disease
(Romagnoli et a1., 1997).
Further immunohistochemical evalua-
tion of T cells in both HlV-negative and
HlV-positive individuals showed a majority
of CD8* rather than CD4* cells equally dis-
tributed throughout the buccal mucosa in
cases where these patients were OPC-nega-
tive, irrespective of blood CD4+ cell num-
bers. In contrast, CD8* cells in lesions from
HIV-positive/OPC-positive persons were
present in significantly higher numbers, and
concentrated at the lamina propria--epithe-
lium interface, a considerable distance from
the Candida at the outer epithelium. Dual
fluorescence and confocal microscopv
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confirmed that the majority of CD8*, but
not CD4* cells, were T cells by the presence
or absence, respectively, of CD3 on each cell
type. These results suggest hat CDS* T cells
may be important for oral host defense
against OPC, especially when CD4+ T cell
numbers are reduced (Myers et al., 2003).
Cbancteiaation of the inflammatory cell
inhltrate in oral mucosal biopsy material of
chronic hyperplastic candidiasis (Williams
et al., 1997) showed that T lymphocytes
were the dominant cell type, with fewer
macrophages and B lymphocytes. Many Ig-
containing cells were seen, and although IgG-
containing cells predominated, there was a
high proportion of IgA-containing cells with
few IgM-containing cells. Many neutrophils,
together with smaller numbers of T lympho-
cytes and macrophageq were seen in the
epithelium. These authors have suggested
that mucosal defense Io Candida infection
involves a cell-mediated reaction in which
there is recruitment of macrophages and
local production of immunoglobulin with a
prominent IgA component.
4.2. Mouse Models
Mucosal candidiasis has been studied in
a number of different models-gastroin-
testinal (GI), vaginal, and oral-and it has
perhaps been too readily assumed that
results obtained from infection of one par-
ticular mucosal site (e.g., the GI tract) can
be extrapolated to other manifestations of
the disease. It has recently become clear that
this is not the case (Fidel, 2002), and that
there may be significant differences in the
"mix" of adaptive and innate immune
responses that mediate responsiveness to
Candida at the different mucosal sites.
Nevertheless, many'valuable insights have
been obtained by Balish and colleagues
using infection of the GI tract, and in the
following discussion, attempts will be made
to integrate these findings with those from
the various oral models.
Models used for the study of oral can-
didiasis have been of three kinds: those
using normal mice (Lacasse et al., 1993;
Elahi et al., 2000; Farah et al., 2001a), those
using immunodeficient mice (Farah et al.,
2002b), and those that involve conditioning
by treatment with immunosuppressive drugs
(Kamai et a1.,2001;' Takakura et al., 2003).
4.2.1, Studies in Normal Mice
In general, the study of oral infection in
normal mice has sought to identify crucial
host variables by comparison of responses
in genetically defined inbred mice. In inbred
mice, oral candidiasis closely resembles the
human disease (Farah et al., 2002b).
BALB/c and DBA/2 mice are of the same
major histocompatibility complex (MHC)
type, but BALB/c is C5-suflicient, whereas
DBN2 is C5-def,rcient. Although DBN2
mice were somewhat more prone to infec-
tion than BALB/c mice (Chakir et al., 1994),
oral infection in both strains resulted in
an increase in MAC-I* cells and a compara-
ble recruitment of CD4+ and CD8* T lym-
phocytes into the mucosal tissue. Thus, in
contrast to systemic infection, complement-
derived chemotactic factors appear to have
little or no effect on inflammatory processes
in the oral mucosa. In addition, the number
of intraepithelial CD4* T cells was hve- to
sevenfold greater in infected animals when
compared to control mice (Deslauriers et al.,
1995). Using the same mouse strains, Elahi
and colleagues (2000) demonstrated signifi-
cantly higher Candida-spec|fi c proliferation
by cells from the draining lymph nodes of
BALB/c as compared to DBA/2 mice, after
oral infection.
Although these studies in vitro strongly
implicated T cells in the host response
against oral infection, initial attempts to
demonstrate their essential role in host
resistance in normal mice by antibody
depletion of CD4 or CD8 cells mice were
unsuccessful. However, when the head and
neck were irradiated, at a dose sufficient to
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block lymphocyte proliferation, depletion of
CD4+, but not CD8+, lymphocytes caused a
prolongation of infection and increased the
severity of oral lesions (Farah et a1., 2001b).
This was interpreted as indicating that the
immune response in the oral cavity was
essentially self-contained, but that CD4+
cells from the systemic circulation had the
potential to exert a protective effect. An
alternative, but not mutually exclusive
explanation, is that irradiation-induced tis-
sue damage favored further proliferation of
the yeast. This could place additional
demands on the local immune response,
resulting in recruitment of CD4'cells from
the peripheral circulation. In the irradiated
mice,.recovery from infection was associated
with production of high levels of IL-12 by
lymph node cells, but concentrations of
IFN-1 in infected mice were comparable to
those in controls.
The importance of T cells and cell-
mediated immunity in oral candidiasis has
been'supported by studies in infectious dis-
ease models. Mice infected with the
Du5H(G6T2) mixture of mouse leukemia
viruses develop a disease (murine AIDS or
MAIDS) that exhibits many of the immune
abnormalities found in human HIV infec-
tion. When these animals were orally colo-
nizetl with C. albicans, approximately 30%
developed recurring 2- to 3-week episodes of
acute Candida proliferation, which were
thought to result from virally induced fluc-
tuations in the levels of CD4* T cells
(Deslauriers et al., 1991). Similarly, trans-
genic mice that expressed HIV type I in
immune cells (de Repentigny et al., 2002)
showed a sustained enhancement of oral
burdens of C. albicaLas, penetration by
Candida hyphae of the stratified squamous
epithelium of the oral cavity, and a mononu-
clear inflammatory cell infiltrate in the
mucosa.
These results are generally consistent
with those derived from models of orogas-
tric candidiasis. Euthymic mice infected in
this manner developed Candida-specifrc
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lymphoproliferative and delayed-type hyper-
sensitivity (DTH) responses that correlated
with the clearance of hyphae from mucosal
surfaces (Balish et al., 1990). Conversely,
depletion of CD4* lymphocytes from T cell-
suffrcient bglbg nul* mice using an anti-CD4
monoclonal antibody increased their sus-
ceptibility to Candida infection of the
tongue and esophagus (Cantorna and
Balish, 1991), and confirmed that the CD4*
cell population was crucial for protection of
mice from orogastric candidiasis, although
neither IL-2 nor IFN-1 was essential for an
effective host response. In disseminated can-
didiasis, the different subsets of CD4* T
helper cells, and cytokines produced by
them, show a strong correlation with sus-
ceptibility and protection from infection
(Romani, 1999), and parallels have been
drawn between this and GI infection.
For example, BALB/c mice are resistant
to systemic challenge with an avirulent iso-
late of C. albicans, and protective host
responses are associated with a Thl
cytokine profrle (Romani et al., 1993). In
contrast, systemic infection of these mice
with a virulent isolate causes early mortality,
whereas GI colonization with the virulent
yeast results in the production of both Thl-
and Th2-type cytokines by CD4* cells from
Peyer's patches and mesenteric lymph nodes,
and clearance of the yeast from the intestine
(Cenci et al., 1995). DBAl2Ct mice develop
fatal disseminated candidiasis after intra-
venous infection with the avirulent strain of
C. albicans (Romani et al., 1993), but intra-
gastric inoculation with the virulent strain
was again associated with the induction of
Thl-type cell-mediated immune responses
and eventual clearance of the infection
(Bistoni et al., 1993).
These data suggest that activation of
Thl-type cytokine responses is associated
with recovery from orogastric Candida
infection, but the nature of the effector
pathways, and the relevance of the Th2Jike
response in the "resistant" BALB/o strain,
have not yet been resolved.
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4.2.2. Studies in
lmmunodeficient Mice
C. albicans is recognized as an organism
that is uniquely adept in exploiting deficien-
cies in host responsiveness, and significant
advances have been made in understanding
yeast-host relationships by the use of
mutant and genetically modified mice. In
humans, cellular immunodeficiency, partic-
ularly that associated with HIV infection,
substantially increases the risk of mucosal
infections with C. albicans, and this condi-
tion has been modeled by the use of the T
cell-deficient "nude" mouse.
Nude mice were shown to be markedly
more susceptible to oral infection than
euthymic controls (Farah et al., 2002b),
and developed a chronic infection. There
was extensive hyphal penetration of the oral
epithelium, associated with inhltration of
PMNLs and the formation of microab-
scesses. Mice of the CBA/CaH strain
that are predisposed to severe tissue pathol-
ogy (Ashman and Papadimitriou, 1987)
acquired a greater fungal burden and devel-
oped more severe lesions after oral infection
than the "low pathology" BALB/c mice.
This is consistent with the regulation of
tissue susceptibility by the Cargl gene
(Ashman, 1998). Established infections in
nude mice could be cleared by the adoptive
transfer of syngeneic lymphocytes (Farah
et a1.,2002b), and the protective effect was
mediated by the CD4*, but not the CD8*
lymphocyte subset. After reconstitution,
IFN-1and IL-12 were produced by lympho-
cytes from the cervical and submaxillary
lymph nodes of the infected mice, but IL-4
and IL-10 were generally not detected.
Similar conclusions have been drawn
from studies of orogastric candidiasis. Nude
mice were unable to clear Candida from the
stomach or the tongue (Balish et a1., 1990),
and did not develop either DTH or lympho-
proliferative responses to C. albicans anti-
gens. After intragastric or oral inoculation,
both SCID mice. which lack functional T
and B cells, and multiply-immunodeficient
(bglbg, nulnu) mice, which are deficient in
both T cells and phagocytic cells, develop a
persistent GI infection, whereas mice that
lack only phagocytic cells (bglbg, nul') arc
able to clear the infection efficiently
(Cantorna and Balish, 1990). Transgenic
epsilon 26 mice have defects in both natural
killer cells and T cells and are highly suscep-
tible to oro-esophageal and gastric candidi-
asis (Balish et a1., 2001), but resistant to
acute systemic candidiasis and systemic can-
didiasis of endogenous origin. Granulocytes
were the major effector population responsi-
ble for protection against systemic infection
(Balish et al., 2001), whereas T cells
appeared to be essential for protection
against mucosal infection. In contrast, B cell
knockout (KO) mice, which lack both
functional B cells and antibodies, were
as resistant to orogastric candidiasis as
immunocompetent controls (Narayanan
et al., 1991), further substantiating a con-
vincing case that cell-mediated immunity
plays a central role in host protection
against mucocutaneous candidiasis.
4,2.3. yl6T Cells
The y16 subset of T cells represents an
iinportant component of the mucosal
immune system that has been implicated in
the process of host defense against the yeast.
In BALB/c and DBA/2 mice, oral infection
with C. albicans resulted in an expansion of
the /6 cell population (Chakir et al., 1994;
Elahi et al., 2000), although the strains
showed different kinetics, with the influx
commencing on day 3 in the BALB/o mice,
but on day 5 in the DBA/2 strain (Chakir
et al.,1994). In both strains, the increase in
/6 cell numbers was associated with a sub-
stantial decrease in the number of viable
organisms recovered from the mucosal tis-
sue. Oral colonization of B cell-deficient
mice, which have a normal T cell response,
increased the number of both odB and /6 T
cells in the GI mucosa (Jones-Carson et al..
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1997), and an accumulation of y/6 T cells in
the peritoneal cavity was also observed after
intraperitoneal infection of immunocomoe_
tent and KO mice with C. albicans (Jones_
Carson et al., 1995). In vitro, the /6 T cells
enhanced nitric oxide production and
macrophage candidacidal activit* and
depletion in vivo abrogated expression of
inducible NO synthase in the mucosa and
enhanced susceptibility to Candida infec_
tion. Interestingly, mice lacking both c/B
and /6 T cells were found to be susceptible
to orogastric candidiasis, but not to acute
g1{emic candidiasis (Jones-Carson et al.,
2000), patterns of susceptibility that are
similar to those seen in nude mice (Ashman
et a1.,2004).
4.2.4. Role of Cytokines
In systemic candidiasis, the roles of the
Thl and Th2 cytokines as regulators of host
lmmune responses have been well estab_
lished (Romani, 1999),whereas in oral infec_
tion, the identity of the cytokine mediator(s)
of host resistance remains elusive and tire
relationship seems more complex. In gen_
eral, IL-12 and IFN-y were the dominant
cytokines produced by lymphocytes from
the draining lymph nodes of recoverins ani_
mals (Farah et al.,200la), but levels oifl,_+
and IL-10 did not show any association with
recovery from oral infection. TNF-cx was the
only cytokine that appeared to be unique to
infected oral mucosa (Farah et al.,200)a\. A
comparison of host responses in the rela_
tively resistant BALB/c or infection_prone
DBN2 mice showed that rapid clearaice of
C. albicans from the mucosa of BALB/c
mice was associated with an early increase iri
levels of IL-4, IL-I2, and IFN_1 in cells
from the cervical lymph nodes, whereas in
the infection-prone DBA/2 mice, expression
of message for IL-4 was delayed, and the
levels secreted were lower (Elahi et al..
2000). In BALB/c mice. monoclonal anti_
body neutralization of IL-4 increased the
fungal burden and delayed the clearance of
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the yeast. Thus, IL-4 appears to be an
important mediator of protection in oral
candidiasis. In contrast, IL_12_deficient
mlce were highly susceptible to primary GI
infection and showed an elevatid produc_
tion of tL-4 with a concomitant reduction in
IFN-1 (Mencacci et al., l99g). Treatment of
mice with GI candidiasis by administration
of soluble IL-4 receptor (sIL_4R) acceler_
ated clearance of the yeast from the stomach
and stimulated Thl-associated resistance(Puccetti et al., 1994).
It might have been expected that the use
of mice in which specific cytokine gengs had
been genetically deleted would have enabled
some of these conflicts to be resolved; how_
eveq studies of candidiasis in cytokine KO
mice has confused, rather than clarified the
issue. In one study, IFN-1 KO mice showed
increased susceptibility to both gastric and
systemic candidiasis (Balish et al., l99g),
whereas another reported no effect on either
form of the disease (eian and Cutler, 1997),
and a third found increased mortality of the
KO mice, although the increased susceptibil_
ity did not correlate with the extent of
organ colonization (Kaposzta et al., l99g).
Ablation of IL-10 increased resistance
against both GI (Del Sero et al., 1999) and
systemic (Vazquez-Torres et al., 1999) can_
didiasis, but deletion of the gene for lL_4
had no effect (Kaposzta et al., 199g). Mice
lacking the homologue for the IL_g receptor
showed increased susceptibility to gastric
and acute systemic andidiasis (Balistret al..
1999), with a slower influx of polvmor_
phonuclear neutrophils into infected tissues,
and a reduction in the candidacidal capacity
of these cells.
In contrast, recent studies of oral can_
didiasis in IFN-y, IL-4, IL-10, and iNOS
KO mice have failed to demonstrate any
alteration in the severity or course of the
disease (Farah, unpublished data). In TNF_
a KO mice. there was an early increase in the
fungal burden in the oral cavitv. but the
duration of the infection was noi different
from controls. Infection in IL-12 KO mice.
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however, was similar to that in T cell-defi-
cient nude mice (Farah, unpublished data)
in that the fungal burden in the oral cavity
increased and the infection became chronic,
persisting undiminished for at least 3
months. The precise role of IL-12 as a medi-
ator of host resistance, the anomalous posi
tion of IFN-1, and the importance of IL-4
remain to be resolved. Our failure to identify
a particular cytokine or set of cytokines as a
crucial link in the effector pathway against
the yeast may be due to a redundancy
among the cytokines that masks the effect of
gene deletion in KO mice; however, it is dif-
ficult to evaluate the significance of such
functional overlap in vivo. Alternatively,
there may exist additional effector path-
ways; or there may be significant, as yet
unidentified, differences between the experi-
mental models. Based on the work under-
taken by the authors, a hypothetical
pathway for activation of effector cells in
oral candidiasis is presented inFig.4.2.
4.2.5, Candidacidal Effector
Mechanisms
Although T cells have been shown to be
essential for recovery from oral candidiasis,
neither cx,B nor y6 T cells have any candi-
dacidal or candidastatic effect per se.
Therefore, other cell types are required for
the eridication of the yeasts from the
infected mucosa.
Depletion of neutrophils or inactivation
of macrophages/monocytes increased the
severity of oral infection in BALBic mice,
but had a lesser effect in the CBA/CaH
strain (Farah et a1., 2001a). Ablation of
both cell populations further increased
infection in BALB/c micg but dramatically
exacerbated the fungal burden in the
CBA/CaH strain. In the absence of activa-
tion, Candida killing by phagocytic cells
(both neutrophils and macrophages) is rela-
tively inefficient, but the candidacidal
potential of both cell types is. significantly
enhanced by exposure to Thl-type
cytokines, such as IFN-y and TNF-o. It
thus seems that phagocytic cells play a more
dominant role in the susceptible CBA/CaH
mice than in the resistant strains, although
there was no signihcant difference in clear-
ance of chronic infections in nude mice of
either strain after reconstitution with lym-
phocytes (Farah et al., 2002b).
Nevertheless, recent studies in nude mice
have thrown further light on the critical role
of the bone marrow in the determination of
tissue susceptibility to infection with C. albi-
ccns (Ashman and Papadimitriou, 1992).
Bone marrow colony formation in vitro was
unchanged in immunocompetent mice
infected either orally or systemically
(Wanasaengsakul and Ashman, 2004);
however, it was significantly depressed in
chronically infected, "high pathology"
CBA/CaH nude mice, compared to BALB/c.
Reconstitution of nude mice with T cells
significantly increased the colony-forming
response in infected BALB/c, but not in
infected CBA/CaH mice. These results sug-
gest that T cell-mediated enhancement of
phagocytic cell production by the bone mar-
row may be one effector pathway,
The importance of phagocytic cells in
host resistance was confirmed by treatment
of SCID mice with cyclophosphamide
(Balish er al., 1993). This caused severe neu-
tropenia and impairrnent of innate immune
mechanisms, and enhanced their susceptibil-
ity to mucosal candidiasis. Furthermore,
impairment of macrophage function in
SCID mice by administration of poly(I-C)
increased susceptibility to disseminated can-
didiasis of endogenous (GI tract) origin
(Jensen eta1.,1992,1994), but the resistance
of immunocompetent controls to mucosal
candidiasis was not altered by treatment
with poly(I-C) alone. Interference with both
macrophage and neutrophil function was
necessary to render these mice susceptible to
the disease (Jensen et al., 1993).
GI colonization of athymic (Jones-
Carson et al., 1995) and SCID (Yazqtez-
Torres et al.. 1995b) mice with C. albicans
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Figure 4.2. Hlpothetical pathway for activation of effector cells in oral candidiasis. Stimulation
antigen-presenting cells (APC) by antigen(s) of candida results in the production of TNF-g, wh
increases recruitment of inflammatory cells, and augments the candidacidal activity of phagocytic c
early in the course of infection. The APCs secrete IL-12, which drives the differentiation of naiVe CI
T cellq and induces a Thl-type cellular immune response. The Thl cytokines (IFN-1 and rNF-cx)
both separately and synergistically to promote Candida killing by both neutrophils and macrophal
while both IL-12 and IFN-1 act on the APC in a feedback loop to enhance their activation.
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stimulated the expression of inducible nitric
oxide synthase (iNOS) in the gastric and
oral mucosa. Inhibition of NO production
in SCID mice enhanced their susceptibility
to orogastric candidiasis, but in athymic
mice, the expression of iNOS was controlled
by y/6 T cells (Jones-Carson et al., 1995)
because depletion of these cells not only
abrogated the expression of iNOS in the
tongue and stomach, but also increased sus-
ceptibility to orogastric candidiasis. In con-
trast, immunocompetent mice did not
express iNOS in the orogastric mucosa after
they were monoassociated with C. albicans
and mucosal candidiasis was not exacer-
bated after treatment with NOS inhibitors
(Jones-Carson et al., 1995). However, no
direct correlation was demonstrable between
nitric oxide production and Candida klllir.g
(Vazquez-Torres et a1., 1995a), suggesting
that nitric oxide was candidastatic rather
than candidacidal, and was associated with
or induced other macrophage candidacidal
mechanisms.
In inbred micg NO was detected in the
effector phase of the response against oral
infection (Elahi et al., 2001b). Concentrations
of NO in the saliva of mice increased after
infection and saliva from infected mice
inhibited the growth of yeast in vitro.
Neutralization of IL-4 in vivo caused a
marked reduction of NO levels in saliva
(Elahi et al., 2001b), and in cultures of cervi-
cal lymph node cells after stimulation with
C. albicans antigen. Conversely, treatment
with NG-monomethyl-r-arginine (MMLA),
which inhibits NO synthesis, led to an
increase in C. albicans in the oral cavity and a
concomitant abrogation of expression
mRNA for IL4, but not IFN-1, in lympho-
cytes from the draining lymph nodes.
Paradoxically, inhibition of IL4 production
was accompanied by an increase in IFN-1
production in susceptible DBN2 mice (Elahi
et al., 2001b), which tends to argue against a
strict ThUTh2 dichotomy as a determinant of
resistance and susceptibility id oral candidia-
sis However, in a different model, treatment
of orally infected mice with aminoguanidine
(AG), which inhibits iNOS, had no effect on
the magnitude or duration of infection
(Farah, unpublished data).
4.2.6. Role of the Infectious
Challenge
The above review of results from models
of oral and GI candidiasis has identifred a
number of common themes in mechanisms
of host defensg but anomalies still remain.
The contrast between the results of Elahi
and Farah is of particular interest, as both
groups were using the same isolate of the
yeast (3630, from the Mycology Reference
Laboratory at the Royal North Shore
Hospital). After oral infection, DBAJ2 mice
showed a bimodal pattern of colonization
(Chakir et al., 1994), a feature reproduced
by Elahi et al. (2000), whereas in the experi-
ments of Farah (Ashman et al., 2003), only
a single peak was observed. It seemed prob-
able that the course of oral infection in this
mouse strain was influenced by the actual
technique used for infection. Elahi et al.
(2000) pressed the yeast onto the gums using
a small swab, whereas Farah et al. (2001a)
introduced a suspension of yeasts into the
mouth, without damaging or traumatizing
the oral mucosa. Thus, in the former case,
microtrauma may have facilitated both
deeper penetration of the yeast and the
rapid elicitation of protective cell-mediated
immune response. When inoculation was
atraumatic, adhesion of the yeast to the oral
mucosa may have been more diffrcult to
establish, and innate immune mechanisms
more directly involved, leading to more
effective resistance against initial coloniza-
tion by the yeasts.
This observation led us to test the
hypothesis that there was a gradation in host
responses from innate to adaptive immunity,
which was determined by the severity of the
infectious challenge. Nude mice develop
chronic infections after oral challenge with
108 yeasts. However, as the doses used for
infection were progressively decreased, the
magnitude of the fungal burden in the
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chronically infected mice decreased propor-
tionally, until eventually, the nude mice were
able to clear the infection completely
(Ashman et al., 2004). Thus. the require-
ment for CD4+ T cells for clearance of the
infection in these mice apparently relates to
the immunological deficit that permitted the
infection to become established-a situation
comparable to the susceptibility to oropha-
ryngeal candidiasis of HIV/AIDS patients'
It is noteworthy that in neither the human
nor the experimentai model is there any sys-
temic dissemination of the mucosal infec-
tion, suggesting that innate immunity may




The genetic background of the mice influ-
ences the nature and magnitude.of C*d'd1-
specific memory responses ln systemlc
infection, in that the susceptible CBAJCaH
mice tend to show lower cell-mediated
immune responses (Ashman, 1990)' but
greater levels of antibody-mediated protec-
tion (Ashman and Papadimitriou, 1988) than
the more resistant BALB/c strain' However,
following oral infection, Candida-speclftc
DTH responses developed in the relatively
infection-proneDBN2, but not in the more
resistant BALB/c mice (Chakir et al', 1994)'
Humoral immune responses were detectable
after infection had resolved (Elahi et al',
2000), but levels of serum IgG and salivary
IgA antibodies were higher in BALB/c than
in DBAJ2 mice. In neonatal micg primary
infection of the GI tract primed them for
enhanced DTH responses and conferred pro-
tection from systemic challenge as adults
(Domer, 1988), whereas adult mice infected
via the oral cavity, but not intravenously, were
protected against a second oral infection
(narah, unpublished data). However, neither
serum nor cells from orally or systemically
immunized mice, transferred into naive
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recipients. was able to protect against oral
challenge.
5. ProsPects for Vaccination
Vaccination against C. albicans is a chal-
lenge, because of the commensal nature of the
organism and because humans are colonized
with the yeast in the early postnatal period'
A thorough understanding of the mechanisms
that confer protective immunity is fundamen-
tal to successful vaccine design, particularly in
view of the problems inherenl in delivering
protection to mucosal surfaces' Direct immu-
nization of the oral cavity has been shown to
have therapeutic potential in mice (Elahi et al',
2001a). Mice given the oral vaccine had a
reduction in colonization associated with
increased levels of secretion of IFN-I and IL-
4 from the regional node cells and increased
levels of nitric oxide in saliva' The use of
mannan -protein conjugates as immunogens
has been shown to have potential (Han et al''
1999), but perhaps a more exciting approach
is the use of cytokines as adjuvants (Deepe'
1997). Another approach to vaccination
against oral C. albicans infection has been the
uie of oral Lactobacillus acidophilus (LAVRI-
A1) to induce local cytokines and enhance
clearance (Elahi et al., 2003)' Protecttve antt-
bodies against C. albicans, including a human
recombinant mAb specihc for C' albicans
hsp90 (Mycofab), are also being evaluated
(Matthews and Burnie, 2001)'
Vaccination of the immunocompronxsed
host represents a further challenge. as vaccines
that rely on a competent immune system are
unlikely to be useful in immunodeficient
patients. In these cases' protective antibodies
could be more benehcial than cellular immu-
nity because of the longevity of the circulating
uniibodi.t. Ultimately though. a vaccine in
these patients will not succeed unless it is
linked with attempts to restore the integrity of
the immune system. This might be done by
delivering the vaccine with cytokines that are
known to enhance the immune response
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(Deepe, 1997), or introducing the vaccine with
immunocompetent T or B cells, to promote its
immunogenic potential.
6. Gonclusion
There is now convincing evidence, both
clinical and experimental, that cell-mediated
immunity is crucial to host recovery from
oral or OPC. This infection, however,
appears to demonstrate a gradation between
the involvement of the innate and adaptive
immune responses, depending on the sever-
ity of the challenge. CD4+ lymphocytes are
certainly involved in the more severe mani-
festations of the disease, but the precise
pathways through which they interact with
the phagocytic gffector cells that clear the
infection have yet to be completely eluci-
dated. Oral immunization can confer pro-
tection, but again, the mechanisms by which
this is achieved require further investigation.
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